| 注册
首页|期刊导航|中国中药杂志|祛瘀解毒中药在肝癌防治中的应用

祛瘀解毒中药在肝癌防治中的应用

陈慧 周丽萍 魏小曼 赖岳阳 闫秋莹 李柳 沈卫星 程海波 孙东东

中国中药杂志2026,Vol.51Issue(10):2970-2982,13.
中国中药杂志2026,Vol.51Issue(10):2970-2982,13.DOI:10.19540/j.cnki.cjcmm.20260106.502

祛瘀解毒中药在肝癌防治中的应用

Application of TCM for dispelling stasis and detoxification in prevention and treatment of liver cancer

陈慧 1周丽萍 1魏小曼 2赖岳阳 3闫秋莹 4李柳 2沈卫星 2程海波 2孙东东5

作者信息

  • 1. 南京中医药大学 中医学院,江苏 南京 210023
  • 2. 南京中医药大学 第一临床医学院,江苏 南京 210023||江苏省中医药防治肿瘤协同创新中心,江苏 南京 210023||南京中医药大学附属医院,江苏 南京 210029
  • 3. 南京中医药大学 第一临床医学院,江苏 南京 210023
  • 4. 江苏省中医药防治肿瘤协同创新中心,江苏 南京 210023
  • 5. 南京中医药大学 中医学院,江苏 南京 210023||南京中医药大学 第一临床医学院,江苏 南京 210023||江苏省中医药防治肿瘤协同创新中心,江苏 南京 210023||南京中医药大学附属医院,江苏 南京 210029
  • 折叠

摘要

Abstract

Liver cancer is a common malignancy with high lethality,and its development is closely associated with liver Qi stagnation,impaired blood circulation,and the long-term accumulation of stasis generating toxin,in which toxin arising from stasis represents a key pathogenic driver.The core mechanism of liver cancer is characterized by stasis-toxin interlocking,and the therapeutic approach of dispelling stasis and detoxifying-guided by the principle of promoting circulation to resolve stasis and clearing toxin at its root-has become a major strategy in prevention and treatment.Through distinct methods such as moving Qi to dispel stasis and remove toxin,clearing heat to eliminate stasis and remove toxin,softening hardness to resolve stasis and remove toxin,and tonifying Qi to dispel stasis and expel toxin,this approach exerts important benefits in liver cancer management.The approach of moving Qi focuses on soothing the liver,promoting Qi movement,and alleviating stasis obstruction,exemplified by formulas such as Gexia Zhuyu Decoction,with Chuanxiong Rhizoma,Curcumae Rhizoma,and Curcumae Radix commonly used.The heat-clearing strategy emphasizes clearing heat,detoxifying,dissipating mass,and dispersing stasis,represented by Longdan Xiegan Decoction,and often incorporates Forsythiae Fructus,Polygoni Cuspidati Rhizoma et Radix,and Moutan Cortex.The softening-hardness approach aims to soften hardness,dissipate mass,eliminate toxin,and resolve stasis,with representative formulas such as Biejiajian Pills and key TCMs including Scolopendra,Gleditsiae Spina,and Prunellae Spica.The Qi-tonifying approach highlights reinforcing healthy Qi,consolidating root,and promoting stasis resolution,represented by formulas such as the Yiqi Huayu Jiedu Prescription,commonly combining Astragali Radix,Notoginseng Radix et Rhizoma,and Agrimoniae Herba.Modern pharmacological studies demonstrate that these stasis-removing and detoxifying TCMs exert anti-liver cancer effects through mechanisms such as cell-cycle arrest,enhancement of mitochondrial-dependent apoptosis,inhibition of tumor angiogenesis,and suppression of proliferation,migration,and invasion of tumor cells,as well as partial reversal of chemoresistance.Their actions involve the coordinated regulation of multiple cancer-related signaling networks,including inhibition of STAT3,NF-κB,PI3K/Akt,TGF-β/Smad pathways,attenuation of pro-inflammatory and pro-proliferative signaling,modulation of the tumor immune microenvironment,alleviation of chronic inflammation,suppression of HIF-1α-mediated and VEGF-mediated angiogenesis,regulation of oxidative stress,and influence on epigenetic processes such as histone acetylation.By systematically summarizing the multi-target and multi-layered action characteristics and potential regulatory mechanisms of these TCM strategies,this study provides a theoretical foundation and therapeutic perspective for understanding and applying stasis-removing and detoxifying TCMs in the management of liver cancer.

关键词

肝癌/祛瘀解毒法/瘀毒互结/癌毒病机理论/中西医结合

Key words

liver cancer/therapeutic approach of dispelling stasis and detoxifying/stasis-toxin interlocking/pathogenesis theory of cancer toxin/integrated traditional Chinese and western medicine

引用本文复制引用

陈慧,周丽萍,魏小曼,赖岳阳,闫秋莹,李柳,沈卫星,程海波,孙东东..祛瘀解毒中药在肝癌防治中的应用[J].中国中药杂志,2026,51(10):2970-2982,13.

基金项目

国家重点研发计划"中医药现代化"重点专项(2022YFC3500201) (2022YFC3500201)

江苏省中医药领军人才培养项目(SLJ0312) (SLJ0312)

南京中医药大学中医肿瘤癌毒病机"揭榜挂帅"专项(AD202402) (AD202402)

中国中药杂志

1001-5302

访问量0
|
下载量0
段落导航相关论文